IDEXX Laboratories, Inc. vs iShares MSCI China ETF — how do they compare? IDEXX Laboratories, Inc. trades at $559.12 (market cap $44.48B), while iShares MSCI China ETF trades at $54.2. Which is the better fit depends on your goals.
| IDXX | MCHI | |
|---|---|---|
Market Cap | $44.48B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $766.68 | $66.99 |
52-Week Low | $520.87 | $50.48 |
Enterprise Value | $45.38B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
MCHI trades at $54.08, up 2.13% today, but technical indicators signal a bearish trend with moving averages showing sell pressure. The stock lacks key valuation metrics like P/E and P/S, and recent news highlights China's economic stimulus focus and AI sector growth, which could impact this China-focused ETF. Dividend activity is scheduled for mid-2026.
The outlook is cautious due to bearish technicals and macroeconomic risks from U.S.-China tensions, though AI-driven exports offer growth potential. Investors face value trap risks amid mixed analyst sentiment, requiring close monitoring of China's policy developments and corporate earnings for directional cues.
Trailing returns across standard periods
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →